113 related articles for article (PubMed ID: 6246753)
1. Opiate and neuroleptic receptor alterations in human schizophrenic brain tissue.
Reisine TD; Rossor M; Spokes E; Iversen LL; Yamamura HI
Adv Biochem Psychopharmacol; 1980; 21():443-50. PubMed ID: 6246753
[No Abstract] [Full Text] [Related]
2. Abnormal neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
[TBL] [Abstract][Full Text] [Related]
3. Alterations in brain opiate receptors in Parkinson's disease.
Reisine TD; Rossor M; Spokes E; Iversen LL; Yamamura HI
Brain Res; 1979 Sep; 173(2):378-82. PubMed ID: 226215
[No Abstract] [Full Text] [Related]
4. Consequences of perinatal drug administration on brain development: striatal opiate receptors and dopamine.
Moon SL
NIDA Res Monogr; 1985; 62():129-45. PubMed ID: 3001526
[No Abstract] [Full Text] [Related]
5. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
[TBL] [Abstract][Full Text] [Related]
6. Dopamine receptor changes in schizophrenia in relation to the disease process and movement disorder.
Cross AJ; Crow TJ; Ferrier IN; Johnstone EC; McCreadie RM; Owen F; Owens DG; Poulter M
J Neural Transm Suppl; 1983; 18():265-72. PubMed ID: 6135745
[No Abstract] [Full Text] [Related]
7. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
Seeman P
Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008
[TBL] [Abstract][Full Text] [Related]
8. Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride.
Seeman P; Niznik HB; Guan HC
Arch Gen Psychiatry; 1990 Dec; 47(12):1170-2. PubMed ID: 2244801
[No Abstract] [Full Text] [Related]
9. Alteration of dopamine receptors in the caudate nucleus and the putamen in schizophrenic brain.
Mjörndal T; Winblad B
Med Biol; 1986; 64(6):351-4. PubMed ID: 2881030
[TBL] [Abstract][Full Text] [Related]
10. Brain enkephalin receptors in Parkinson's disease.
Rinne UK; Rinne JK; Rinne JO; Laakso K; Tenovuo O; Lönnberg P; Koskinen V
J Neural Transm Suppl; 1983; 19():163-71. PubMed ID: 6321647
[TBL] [Abstract][Full Text] [Related]
11. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia.
Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL
Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577
[TBL] [Abstract][Full Text] [Related]
12. Increased dopamine-receptor sensitivity in schizophrenia.
Owen F; Cross AJ; Crow TJ; Longden A; Poulter M; Riley GJ
Lancet; 1978 Jul; 2(8083):223-6. PubMed ID: 79025
[TBL] [Abstract][Full Text] [Related]
13. Dopamine receptor binding of C-11-3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: a preliminary report.
Wong DF; Wagner HN; Pearlson G; Dannals RF; Links JM; Ravert HT; Wilson AA; Suneja S; Bjorvvinssen E; Kuhar MJ
Psychopharmacol Bull; 1985; 21(3):595-8. PubMed ID: 4034877
[No Abstract] [Full Text] [Related]
14. Dopamine receptors, neuroleptics, and schizophrenia.
Snyder SH
Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
[TBL] [Abstract][Full Text] [Related]
15. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptors in schizophrenia.
Gjedde A; Reith J; Wong D
Lancet; 1995 Nov; 346(8985):1302-3. PubMed ID: 7475750
[No Abstract] [Full Text] [Related]
17. Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone.
Hägglund J; Aquilonius SM; Eckernäs SA; Hartvig P; Lundquist H; Gullberg P; Långström B
Acta Neurol Scand; 1987 Feb; 75(2):87-94. PubMed ID: 2953165
[TBL] [Abstract][Full Text] [Related]
18. Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET.
Arnett CD; Wolf AP; Shiue CY; Fowler JS; MacGregor RR; Christman DR; Smith MR
J Nucl Med; 1986 Dec; 27(12):1878-82. PubMed ID: 3491193
[TBL] [Abstract][Full Text] [Related]
19. Effect of lithium and sodium ions on opiate- and dopamine-receptor binding.
Wajda IJ; Banay-Schwartz M; Manigault I; Lajtha A
Neurochem Res; 1981 Mar; 6(3):321-31. PubMed ID: 6269012
[TBL] [Abstract][Full Text] [Related]
20. Developmental relationships between opiate receptors and dopamine in the formation of caudate-putamen patches.
van der Kooy D
Brain Res; 1984 Jun; 316(2):300-3. PubMed ID: 6087996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
